Keystone EC - Search Results

1

Therapeutic implications for interferon-alpha in arthritis: a pilot study.

Wong T, Majchrzak B, Bogoch E, Keystone EC, Fish EN. Wong T, et al. Among authors: keystone ec. J Rheumatol. 2003 May;30(5):934-40. J Rheumatol. 2003. PMID: 12734885

2

Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.

Keystone E, Freundlich B, Schiff M, Li J, Hooper M. Keystone E, et al. J Rheumatol. 2009 Mar;36(3):522-31. doi: 10.3899/jrheum.080663. Epub 2009 Feb 17. J Rheumatol. 2009. PMID: 19228659 Clinical Trial.

3

Asymmetry of small joint involvement in rheumatoid arthritis: prevalence and tendency towards symmetry over time.

Zangger P, Keystone EC, Bogoch ER. Zangger P, et al. Among authors: keystone ec. Joint Bone Spine. 2005 May;72(3):241-7. doi: 10.1016/j.jbspin.2004.08.013. Joint Bone Spine. 2005. PMID: 15850996

4

Cell-signaling therapy in rheumatoid arthritis.

Keystone E, Cohen MD. Keystone E, et al. Curr Rheumatol Rep. 2013 Oct;15(10):368. doi: 10.1007/s11926-013-0368-5. Curr Rheumatol Rep. 2013. PMID: 23955067 Review.

5

Safety of biologic therapies--an update.

Keystone EC. Keystone EC. J Rheumatol Suppl. 2005 Mar;74:8-12. J Rheumatol Suppl. 2005. PMID: 15742458 Review.

6

Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts.

Hazlewood GS, Bombardier C, Li X, Movahedi M, Choquette D, Coupal L, Bykerk VP, Schieir O, Mosher D, Marshall DA, Bernatsky S, Spencer N, Richards DP, Proulx L, Barber CEH; OBRI, RHUMADATA, CATCH Investigators, and the Rheum4U Team. Hazlewood GS, et al. J Rheumatol. 2022 Jan;49(1):16-25. doi: 10.3899/jrheum.201688. Epub 2021 Aug 1. J Rheumatol. 2022. PMID: 34334357

7

Optimizing treatment with biologics.

Mader R, Keystone E. Mader R, et al. J Rheumatol Suppl. 2007 Nov;80:16-24. J Rheumatol Suppl. 2007. PMID: 17985419 Review.

8

14-3-3η Autoantibodies: Diagnostic Use in Early Rheumatoid Arthritis.

Maksymowych WP, Boire G, van Schaardenburg D, Wichuk S, Turk S, Boers M, Siminovitch KA, Bykerk V, Keystone E, Tak PP, van Kuijk AW, Landewé R, van der Heijde D, Murphy M, Marotta A. Maksymowych WP, et al. J Rheumatol. 2015 Sep;42(9):1587-94. doi: 10.3899/jrheum.141385. Epub 2015 Jul 15. J Rheumatol. 2015. PMID: 26178283

9

Wasserman MJ, Weber DA, Guthrie JA, Bykerk VP, Lee P, Keystone EC. Wasserman MJ, et al. Among authors: keystone ec. J Rheumatol. 2004 Oct;31(10):1912-7. J Rheumatol. 2004. PMID: 15468353

10

Clinical outcomes of patients with rheumatoid arthritis after switching from infliximab to etanercept.

Haraoui B, Keystone EC, Thorne JC, Pope JE, Chen I, Asare CG, Leff JA. Haraoui B, et al. Among authors: keystone ec. J Rheumatol. 2004 Dec;31(12):2356-9. J Rheumatol. 2004. PMID: 15570634 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

298 results

Search Page

Filters